The cost-effectiveness analysis of single-tablet efavirenz-based regimen among HIV
IntroductionIn 2018, the Chinese Guidelines for Diagnosis
and Treatment of HIV/AIDS recommended the adoption of the efavirenz
400 mg-based TLE ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.